UASt regulatory sequences drive expression of an inverted repeat.
Expression of Bre1GD5127 under the control of Scer\GAL4GMR.PF does not result in eye defects.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 20-30% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 80-90% of the Scer\GAL4pnr-MD237-expressing area of the notum.
Bre1GD5127, Scer\GAL4GMR.PF is an enhancer of visible phenotype of Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa
Bre1GD5127, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, Usp7UAS.cKa, burUAS.cLa
Co-expression of Bre1GD5127 enhances the eye defects caused by co-expression of burScer\UAS.cLa and Usp7Scer\UAS.cKa under the control of Scer\GAL4GMR.PF.